Clinical Trials Logo

Rejuvenation clinical trials

View clinical trials related to Rejuvenation.

Filter by:
  • None
  • Page 1

NCT ID: NCT05840445 Completed - Face Clinical Trials

Efficacy of Prabotulinum and Onabotulinum Toxin-A for Facial Wrinkles

Start date: June 15, 2020
Phase: Phase 4
Study type: Interventional

The appearance of facial wrinkles, lines, or folds is a natural phenomenon during aging. Different scales help classify wrinkles objectively, such as the Facial Wrinkle Scale. Others help classify patients' subjective perspectives, like the Face-Q questionnaire. The application of Botulinum Toxin is the most performed non-surgical aesthetic procedure in the world to treat facial expression lines. The present study aims to compare the efficacy of onabotulinum toxin-A (BOTOX®) and prabotulinum toxin-A (NABOTA®) to treat expression lines in the upper third of the face, based on objective and subjective follow-up, using the FWS scale and FACE-Q questionnaire, respectively.

NCT ID: NCT05694286 Active, not recruiting - Dermal Filler Clinical Trials

A Prospective Evaluation of Infraorbital Filler Injection

Start date: January 6, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to measure the facial volumetric changes over time in patients injected with hyaluronic acid dermal filler (Juvéderm Volbella XC) in the infraorbital (under eye) region. Participants will be injected with Juvéderm Volbella XC filler and asked to return for 3D photography at 2 weeks, 1 month, and 3 months post-injection.

NCT ID: NCT04640207 Completed - Rejuvenation Clinical Trials

The Efficacy of the Alma Hybrid System for a New Approach of Facial Skin Treatment

Start date: November 25, 2020
Phase: N/A
Study type: Interventional

The study is aimed to evaluate the efficacy of the Alma Hybrid system for a new approach of facial skin treatment, using both ablative and non-ablative wavelengths. The study will include 20 subjects with mild-moderate photodamaged skin, that will undergo 2 facial skin treatments. Follow up visit to evaluate the efficacy of the treatments will take place 1 and 3 months after the last treatment.

NCT ID: NCT03767972 Enrolling by invitation - Rejuvenation Clinical Trials

Energy Devices for Rejuvenation

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

Non-ablative and ablative devices are the most commonly used minimally-invasive treatments for skin rejuvenation. Current devices on the market for rejuvenation include the lasers such as the Fraxel Restore, the Halo, the Helios III, the Pico, the ThermiVa and the DiVa which have all been shown to have efficacy for the rejuvenation of the face, décolletage, hands and vagina. In this study we propose to compare the efficacy and side effect profile of these devices for skin rejuvenation of various areas of the body including the face, décolletage, hands, trunk, upper and lower extremities, and vagina.

NCT ID: NCT03189082 Completed - Therapy Clinical Trials

Microbotox for Lower Face Rejuvenation

Start date: August 10, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficiency of the intradermal injection of botulinum toxin in lower face rejuvenation. The study will also compare this intervention with the "Nefertiti Lift" intramuscular injection technique.

NCT ID: NCT02910492 Completed - Rejuvenation Clinical Trials

Study of a Novel Laser for Skin Rejuvenation

Start date: September 2016
Phase: N/A
Study type: Interventional

Single-center study to evaluate the safety and efficacy of an investigational version of the enlighten™ 670nm laser for photo-rejuvenation.

NCT ID: NCT01403597 Completed - Laser Therapy Clinical Trials

Evaluation of Non-ablative and Fractional Combination Treatment for Improvement in Skin's Appearance

Start date: January 2011
Phase: N/A
Study type: Interventional

The study is designed to determine the safety, efficacy, patient comfort and patient satisfaction of the combined treatment of Refirme ST and Matrix RF both devices approved under 510k clearances. The evaluations will include skin condition, physician/subject improvement assessment, and subject comfort and satisfaction score by questionnaires.